↓ Skip to main content

Dove Medical Press

Canagliflozin review – safety and efficacy profile in patients with T2DM

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
95 Mendeley
Title
Canagliflozin review – safety and efficacy profile in patients with T2DM
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2019
DOI 10.2147/dmso.s184437
Pubmed ID
Authors

Haroon Jakher, Tara I Chang, Marilyn Tan, Kenneth W Mahaffey

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 12%
Student > Bachelor 11 12%
Researcher 8 8%
Lecturer 6 6%
Other 4 4%
Other 15 16%
Unknown 40 42%
Readers by discipline Count As %
Medicine and Dentistry 24 25%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Biochemistry, Genetics and Molecular Biology 7 7%
Agricultural and Biological Sciences 2 2%
Unspecified 2 2%
Other 6 6%
Unknown 44 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2019.
All research outputs
#16,108,994
of 25,461,852 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#507
of 1,184 outputs
Outputs of similar age
#255,499
of 447,939 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#8
of 21 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,939 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.